Physician profile
Michael Alleva
NPI 1730147182
$3,308.38
in general payments reported to CMS, 2019-2025
21 companies · $821 in 2025
The $821 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $221 · 2021: $481 · 2022: $274 · 2023: $418 · 2024: $503 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,742.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $606.01 | 2020-2025 | Nucala, Trelegy Ellipta |
| Stryker Corporation | $452.82 | 2019-2025 | Xpress Loprofile, Audion Et Dilation System |
| Genzyme Corporation | $388.91 | 2021-2025 | |
| Optinose US, INC. | $319.21 | 2019-2025 | |
| Alk-Abello, INC | $227.21 | 2020-2025 | Odactra, Grastek |
| Neurent Medical Limited | $216.47 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Regeneron Healthcare Solutions, INC. | $185.80 | 2020-2025 | Dupixent |
| Grifols USA, LLC | $144.77 | 2025 | Xembify |
| Arrinex, INC. | $136.23 | 2019 | |
| Aerin Medical INC. | $116.79 | 2022-2025 | |
| Kaleo, INC. | $108.44 | 2023-2024 | Auvi-Q |
| Lilly USA, LLC | $81.44 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $80.37 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $60.98 | 2022-2023 | Ryaltris |
| Integra Lifesciences Corporation | $45.87 | 2024 | Acclarent Aera |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $33.72 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Uswm, LLC | $23.00 | 2021 | |
| Amgen INC. | $20.85 | 2022 | |
| Phadia US INC. | $20.60 | 2023 | Immunocap |
| Inspire Medical Systems, INC. | $19.79 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $19.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Alleva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.